Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

NCT07463781

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High Grade B Cell Lymphoma, +11 more
Locations: SCDU Ematologia - AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria Alessandria, Italy

Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy

USD-TMO Adulti - ASST Spedali Civili di Brescia Brescia, Italy

Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy

View Trial Details

Not Yet Recruiting

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

NCT07457177

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Reduced Dosage and/or Visitation Protocol for the Treatment of Acute Malnutrition in Kenya

NCT07420062

Conditions: Acute Malnutrition in Childhood, Acute Malnutrition, Moderate, Acute Malnutrition, Severe, +22 more
Locations: West Pokot, Wajir, and Samburu counties Kitale, West Pokot County, Kenya

View Trial Details

Not Yet Recruiting

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

NCT07412405

Conditions: Adult B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +31 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

NCT07410052

Conditions: Cognition Disorders, Cognitive Deficits, Mild, Dyssomnias, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

NCT07398638

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

NCT07385989

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

NCT07180771

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

NCT07355283

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

NCT07367685

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions